ALung Technologies recently announced the initiation of patient enrollment in its VENT-AVOID trails with the Minneapolis Heart Institute Foundation. The trial is pivotal in validating the safety and efficacy of the Hemolung Respiratory Assist System for COPD patients who require ventilatory support.
Recent Posts
MyUPMC experiences major jump in video visits as patients move to online care
More patients than ever are heading for UPMC’s digital front door as the COVID-19 pandemic …
Read More →
Spurred by crisis, telemedicine is revolutionizing health care as we know it
Telemedicine, the remote delivery of health care using video and audio communication tools, is demonstrating …
Read More →